Cardiomyopathy laboratory findings: Difference between revisions
Jump to navigation
Jump to search
Lina Yaqoub (talk | contribs) |
Lina Yaqoub (talk | contribs) |
||
| Line 2: | Line 2: | ||
{{Cardiomyopathy}} | {{Cardiomyopathy}} | ||
Please help WikiDoc by adding content here. It's easy! Click [[Help:How_to_Edit_a_Page|here]] to learn about editing. | Please help WikiDoc by adding content here. It's easy! Click [[Help:How_to_Edit_a_Page|here]] to learn about editing. | ||
* Hyponatremia can be seen in patients with cardiomypathy and other causes of HF: it has prognostic implications; as it indicates the activation of the Renin-Angiotensin system in response to the stress of the cardiomyopathy and/or heart failure. | |||
* Kidney function could be affected as a result of medication-toxicity, volume depletion in cases of excessive diuresis, or development of cardiorenal syndrome. | |||
* Brain natriuretic peptide (BNP) is usually elevated in systolic heart dysfunction: it can also be falsely elevated in renal failure and pulmonary embolism. On the other hand, it can be falsely low in obese patients. | |||
* Elevated troponin levels indicate ischemic heart disease, and should be investigated as much, till coronary arterial disease is ruled out. | |||
* Elevated iron saturation and ferritin are indicative of hemochromatosis as a cause of cardiomyopathy. | |||
==References== | ==References== | ||
| Line 15: | Line 20: | ||
{{WH}} | {{WH}} | ||
{{WS}} | {{WS}} | ||
{{Sisakian H. Cardiomyopathies: Evolution of pathogenesis concepts and potential for new therapies. World J Cardiol. 2014;6(6):478-94}} | |||
Revision as of 17:07, 16 December 2018
|
Cardiomyopathy Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Guidelines |
|
2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy |
|
Case Studies |
|
Cardiomyopathy laboratory findings On the Web |
|
American Roentgen Ray Society Images of Cardiomyopathy laboratory findings |
|
Risk calculators and risk factors for Cardiomyopathy laboratory findings |
Please help WikiDoc by adding content here. It's easy! Click here to learn about editing.
- Hyponatremia can be seen in patients with cardiomypathy and other causes of HF: it has prognostic implications; as it indicates the activation of the Renin-Angiotensin system in response to the stress of the cardiomyopathy and/or heart failure.
- Kidney function could be affected as a result of medication-toxicity, volume depletion in cases of excessive diuresis, or development of cardiorenal syndrome.
- Brain natriuretic peptide (BNP) is usually elevated in systolic heart dysfunction: it can also be falsely elevated in renal failure and pulmonary embolism. On the other hand, it can be falsely low in obese patients.
- Elevated troponin levels indicate ischemic heart disease, and should be investigated as much, till coronary arterial disease is ruled out.
- Elevated iron saturation and ferritin are indicative of hemochromatosis as a cause of cardiomyopathy.
References
Template:WH Template:WS Template:Sisakian H. Cardiomyopathies: Evolution of pathogenesis concepts and potential for new therapies. World J Cardiol. 2014;6(6):478-94